CSL’s Response to COVID-19
Despite the constantly challenging environment the COVID-19 pandemic has presented to the world, CSL has remained steadfast in our promise to safeguarding our patients, our plasma donors and our employees. As the pandemic continues to evolve, so have we. CSL has redirected resources and taken on extra commitments to protect public health where we could offer the most value, including our expertise, technologies, equipment and materials. And through it all, we continue to deliver on our promise for those who need us most, our patients.Read More About CSL Behring's Efforts with COVID-19
Rare Disease Day Events
Both EURORDIS and the U.S. National Institutes of Health are offering virtual events in February that highlight research and …
How Do You Find a Clinical Trial?
A new, user-friendly guide – soon to be an app – helps sickle cell disease patients who are considering joining research tria…
Harnessing Talent for Vaccine Innovation
University of Illinois’ Nicholas Wu wins Seqirus-supported award for vaccine research.
Did you know? Bern, Switzerland is one of the most Instagrammed winter locales and it’s home to a CSL Behring manufacturing a…
The Secret to a Cleaner House
People who live with chronic illness and other conditions can use goal-setting and time-management strategies to tidy up at h…
Extraordinary! A Book for Kids with Rare Diseases
We chatted with mother-and-son team Evren and Kara Ayik, authors of a new book that’s for, and about, kids who have rare dise…
CSL Plasma App Gets an Upgrade
Donors will find an updated news section, info for users who have a disability and tips on the referral program.
Employee Wins USA TODAY Animalkind Award
Allen and his wife established a dog hospice that teaches lessons, changes lives and warms hearts.